Samsara BioCapital’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-5,161,888
| Closed | -$198M | – | 48 |
|
|
2023
Q2 | $198M | Hold |
5,161,888
| – | – | 34.81% | 1 |
|
|
2023
Q1 | $119M | Hold |
5,161,888
| – | – | 24.7% | 1 |
|
|
2022
Q4 | $135M | Hold |
5,161,888
| – | – | 29.11% | 1 |
|
|
2022
Q3 | $101M | Hold |
5,161,888
| – | – | 23.66% | 1 |
|
|
2022
Q2 | $90.3M | Buy |
5,161,888
+570,000
| +12% | +$9.97M | 24.07% | 1 |
|
|
2022
Q1 | $75.1M | Hold |
4,591,888
| – | – | 18.91% | 1 |
|
|
2021
Q4 | $74.9M | Buy |
4,591,888
+1,215,000
| +36% | +$19.8M | 14.53% | 2 |
|
|
2021
Q3 | $43.1M | Buy |
3,376,888
+208,500
| +7% | +$2.66M | 6.76% | 3 |
|
|
2021
Q2 | $44.7M | Hold |
3,168,388
| – | – | 5.52% | 3 |
|
|
2021
Q1 | $49.2M | Hold |
3,168,388
| – | – | 9.08% | 2 |
|
|
2020
Q4 | $50.3K | Buy |
+3,168,388
| New | +$50.3K | 5.05% | 3 |
|